Our website uses its own and third parties cookies for a high level of user-friendliness. If you continue to browse and  use this website we will assume that you agree with the policies.

R&D

Zitomab. Development of anti-tumor second generation immunotherapies: Antibodies and nanobodies conjugated with toxins through inteins – Zip

The aim of the project is to validate a new platform of specific conjugation of antibodies through the ZIP-Inteins® technology, which is based in the use of inteins as tools for conjugation

 

 

Consortium lead by Zera Intein Protein Solutions S.L., in collaboration with Acondicionamiento Tarrasense - LEITAT and Fundació Institut de Recerca biomédica (Barcelona)

Cofunded by the Ministerio de economía y Competitividad, Programa Nacional de cooperación Público-Privada, Subprograma INNPACTO, within the "Instrumental de Articulación e Internacionalización del Sistema", in the frame of the Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica 2008-2011, and by the Fondo Europeo de Desarrollo Regional (FEDER).

ID: RTC-2015-4336-1

2015-2018